+8%

est. 2Y upside i

Series A

Cortical Labs is a biological computing company at the heart of a new era with the world’s first commercial biological computer, the CL1 – available for independent lab use and remote cloud connection.

Rank

#1879

Sector

Biological Computing

Est. Liquidity

~5Y

Data Quality

Data: Low

Cortical Labs offers high-risk, high-reward equity.

Last updated: July 19, 2026

Bull (20%)+80%

Cortical Labs achieves commercial breakthrough with data center and biopharma contracts, driving revenue to $5M by 2028. Exit multiple expands to 30x revenue, yielding 80% net upside after 20% dilution.

Base (55%)+30%

Revenue grows to $2M with steady adoption from research labs. Exit multiple of 20x yields 30% net upside after 20% dilution.

Bear (25%)-100%

Regulatory or ethical hurdles slow adoption; revenue remains below $1M. Exit multiple contracts to 10x, valuation falls below $12M, leaving common stock worth -100% after preference liquidation.

Est. time to liquidity~4.5 years

Preference Stack Risk

high

Funding Intensity

2320%

Total funding of $11.6M represents 23.2% of estimated $50M valuation, creating a high preference overhang.

Dilution Risk

high

As a Series A without disclosed revenue, the company will likely raise additional rounds, diluting current equity by ~20% over 2 years.

Secondary Liquidity

none

No secondary market exists; liquidity only upon acquisition or IPO.

Questions to Ask at the Interview

Strategic questions based on Cortical Labs's data — designed to show you've done your homework.

  • 1

    How does Cortical Labs plan to address ethical concerns regarding consciousness in organoid brains?

  • 2

    What is the unit economics of the CL1 and Cortical Cloud?

  • 3

    What is the expected timeline to liquidity for early employees given the early stage?

Community

Valuation Sentiment

Our model estimates +8% upside. What do you think?

Anonymous. Do not share material non-public information.


Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.